Doing Business in Brazil

Paloma Mansano, Latin America Legal Counsel, Bentley Systems, Incorporated
Fatima Picôto, Legal Director Brazil, GlaxoSmithKline Brasil Ltda

The entry of Brazil into the Emerging Markets Group, leading the Latin America economy, increased the number of players interested in the Brazilian pharmaceutical market. Brazilian Legislation has been in line with most advanced laws, especially in relation to anti-trust and anti-corruption. At the same time the local Regulatory Agency has been worldwide recognized for its outstanding performance. Clinical trials are increasing in the region. In this scenario, how should internal lawyers interact in this new environment? How to be a business partner and act as independent adviser, thinking globally and acting locally, with the proposal of protecting the company globally?

Read full paper Subscribe to the IICJ
Brazil Management Pharmaceutical November 2010 Vol. 4, No. 13, Autumn 2010

Paloma Mansano

More

Paloma Mansano, Latin America and West Europe Legal Head at Bentley

Fatima Picôto

More

GlaxoSmithKline Brasil Ltda

More

Brazil Management Pharmaceutical November 2010 Vol. 4, No. 13, Autumn 2010